Question · asked by 1 review
Amifostine vs no otoprotective intervention: Quality of life
- Population
- children with cancer treated with platinum‐based therapy
- Intervention
- Amifostine
- Comparison
- no otoprotective intervention
- Outcome
- Quality of life
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Amifostine vs no otoprotective intervention Quality of life · children with cancer treated with platinum‐based therapy The review found no eligible studies for this question. Medical interventions for the prevention of platinum‐induced hearing loss in children with cancer (2019) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Medical interventions for the prevention of platinum‐induced hearing loss in children with cancer 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Amifostine vs no treatment/placebo · Patients receiving radiotherapy on its own or in addition to chemotherapy to the head… · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.